Related Experiment Video
Updated: Jun 29, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system
Hiroki Kobayashi1, Ryota Chijimatsu2, Yusuke Naoi1,2
1Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Insights
Researchers discovered a distinct plasmablast-like (PBL) tumor subpopulation in primary central nervous system lymphoma (PCNSL). This finding reveals new insights into PCNSL
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Primary central nervous system lymphoma (PCNSL) is a rare, aggressive lymphoma, often diffuse large B-cell lymphoma (DLBCL).
- Intratumoral heterogeneity in PCNSL, reflecting B-cell states, is not well understood.
- Systemic DLBCL heterogeneity is linked to microenvironment variations.
Purpose of the Study:
- To characterize cellular and spatial heterogeneity in PCNSL.
- To elucidate the microenvironment of PCNSL.
- To identify novel tumor subpopulations and their biological significance.
Main Methods:
- Single-cell and spatial multiomic analyses.
- B-cell receptor (BCR) repertoire sequencing.
- Immunohistochemistry (CD138, CD3+ cell staining).
- Intercellular communication analysis.
Main Results:
- A distinct lymphoma subpopulation with plasmablast (PBL) signature was identified in PCNSL.
- BCR analysis indicated a common origin for PBL signature subpopulations and other lymphoma cells.
- Spatial analysis revealed diverse localization patterns of PBL signature subpopulations.
- Approximately 40% of PCNSL patients exhibited a PBL signature subpopulation.
- PBL signature presence with low CD3+ T-cell infiltration correlated with worse prognosis.
- Distinct intercellular communication patterns were observed for the PBL signature subpopulation.
Conclusions:
- A tumor subpopulation with a PBL signature exists in PCNSL.
- This subpopulation exhibits distinct molecular and spatial interactions with the microenvironment.
- These findings offer new insights into PCNSL pathogenesis and heterogeneity.
Abstract:
Primary central nervous system lymphoma (PCNSL) is a rare, aggressive type of lymphoma, most often histologically diagnosed as diffuse large B-cell lymphoma (DLBCL). Recent advancements in single-cell sequencing have elucidated that the diverse germinal center states in systemic DLBCL manifest as tumor cell diversity, intricately linked to variations in the microenvironment. However, detailed characterization of intratumoral heterogeneity reflecting B-cell states in PCNSL remains elusive. Here, we conducted single-cell and spatial multiomic analyses to elucidate the cellular and spatial heterogeneity and the microenvironment in PCNSL. We identified a distinctive lymphoma subpopulation with gene and protein expression similar to that of plasmablasts (PBLs), enriched in some patients with PCNSL. B-cell receptor (BCR) analysis revealed that BCR clonotypes of the PBL signature subpopulation were shared with other subpopulations, suggesting a common origin with other lymphoma cell subtypes. Spatial analysis additionally revealed several localization patterns of PBL signature subpopulations within the tissue, indicating spatial heterogeneity. An expansion study showed that ∼40% of patients with PCNSL had a PBL signature subpopulation, as defined by CD138 immunohistochemistry staining. Additionally, patients with a PBL signature subpopulation and low CD3+ cell infiltration exhibited a worse prognosis. Finally, intercellular communication analysis suggested that the PBL signature subpopulation had distinct cellular interactions with the microenvironment. In summary, our study identified a tumor subpopulation with a PBL signature in PCNSL, suggesting distinct molecular and spatial cross talk with the microenvironment. These findings provided new insights into the biological mechanisms of PCNSL.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019